$5.25 +0.08 (1.55%) Keryx Biopharmaceuticals - NASDAQ

Sep. 28, 2016 | 04:00 PM
Last Trade: 5.25
Trade Time: Sep 28 04:00 PM Eastern Daylight Time
Change: +0.08 (1.55%)
Prev Close: 5.17
Open: 5.16
Bid: 5.25
Ask: 5.26
  1. No results found.
  1. Back On Track

    TalkMarkets | Sep. 27, 2016 | 23:26PM EST
  2. Seth Klarman Buys 25 Million Shares of Cascadian Therapeutics

    GuruFocus | Jul. 12, 2016 | 10:53AM EST
  3. Klarman Gives Insight on Keryx Biopharmaceuticals Investment

    GuruFocus | Jan. 26, 2016 | 15:04PM EST
  4. Seth Klarman Blames Market, Investments for Rare Down Year

    GuruFocus | Jan. 25, 2016 | 17:04PM EST
  5. Mid-Day Market Update: Cintas Gains On Earnings Beat; NetApp Shares Slide

    Benzinga | Dec. 22, 2015 | 12:20PM EST
  6. David Abrams Buys Stake in Heavy Equipment Company

    GuruFocus | Dec. 15, 2015 | 18:19PM EST
  7. Why Seth Klarman Keeps Buying Keryx Biopharma

    GuruFocus | Nov. 3, 2015 | 12:36PM EST
  8. Seth Klarman Raises Position in Keryx Biopharmaceuticals

    GuruFocus | Oct. 21, 2015 | 17:24PM EST
  9. Mid-Day Market Update: Weight Watchers Jumps On Oprah Stake; Great Lakes Dredge & Dock Shares Drop

    Benzinga | Oct. 19, 2015 | 12:34PM EST
  10. Mid-Afternoon Market Update: Dow Jumps 175 Points; Garmin Shares Slip On Weak Preliminary Q3 Results

    Benzinga | Oct. 15, 2015 | 15:28PM EST
  11. Mid-Day Market Update: Crude Oil Down 2%; Five Prime Therapeutics Shares Spike Higher

    Benzinga | Oct. 15, 2015 | 12:25PM EST
  12. Morning Market Gainers

    Benzinga | Oct. 15, 2015 | 09:48AM EST
  13. Seth Klarman Buys Pharmaceutical Company's Shares to Fund International Drug Launch

    GuruFocus | Oct. 12, 2015 | 17:36PM EST
  14. Morning Market Gainers

    Benzinga | Oct. 5, 2015 | 09:47AM EST
  15. Keryx Pharma: Citigroup Says EU Approval Was As Expected And Doesn't Change The Banks' Sell Thesis, Maintains PT $1.50

    Benzinga | Sep. 24, 2015 | 12:27PM EST
Trading Center